Aasa-Chapman MM, Hayman A, Newton P, Cornforth D, Williams I, Borrow P, Balfe P, McKnight A: Development of the antibody response in acute HIV-1 infection. AIDS. 2004, 18: 371-81. 10.1097/00002030-200402200-00002.
Article
CAS
PubMed
Google Scholar
Lindbäck S, Thorstensson R, Karlsson AC, von Sydow M, Flamholc L, Blaxhult A, Sönnerborg A, Biberfeld G, Gaines H: Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. Karolinska Institute Primary HIV Infection Study Group. AIDS. 2000, 14: 2333-9. 10.1097/00002030-200010200-00014.
Article
PubMed
Google Scholar
Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X, Salazar-Gonzalez JF, Salazar MG, Kilby JM, Saag MS, Komarova NL, Nowak MA, Hahn BH, Kwong PD, Shaw GM: Antibody neutralization and escape by HIV-1. Nature. 2003, 422: 307-12. 10.1038/nature01470.
Article
CAS
PubMed
Google Scholar
Falkensammer B, Freißmuth D, Hübner L, Speth C, Dierich MP, Stoiber H: Changes in HIV-specific antibody responses and neutralization titers in patients under ART. Front Biosci. 2007, 12: 2148-58. 10.2741/2218.
Article
CAS
PubMed
Google Scholar
Sawyer LA, Katzenstein DA, Hendry RM, Boone EJ, Vujcic LK, Williams CC, Zeger SL, Saah AJ, Rinaldo CR, Phair JP: Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection. AIDS Res Hum Retroviruses. 1990, 6: 341-56. 10.1089/aid.1990.6.341.
Article
CAS
PubMed
Google Scholar
Banks ND, Kinsey N, Clements J, Hildreth JE: Sustained antibody-dependent cell-mediated cytotoxicity (ADCC) in SIV-infected macaques correlates with delayed progression to AIDS. AIDS Res Hum Retroviruses. 2002, 18: 1197-205. 10.1089/08892220260387940.
Article
CAS
PubMed
Google Scholar
Forthal DN, Landucci G, Keenan B: Relationship between antibody-dependent cellular cytotoxicity, plasma HIV type 1 RNA, and CD4+ lymphocyte count. AIDS Res Hum Retroviruses. 2001, 17: 553-61. 10.1089/08892220151126661.
Article
CAS
PubMed
Google Scholar
Gómez-Román VR, Patterson LJ, Venzon D, Liewehr D, Aldrich K, Florese R, Robert-Guroff M: Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251. J Immunol. 2005, 174: 2185-9.
Article
PubMed
Google Scholar
Alsmadi O, Herz R, Murphy E, Pinter A, Tilley SA: A novel antibody-dependent cellular cytotoxicity epitope in gp120 is identified by two monoclonal antibodies isolated from a long-term survivor of human immunodeficiency virus type 1 infection. J Virol. 1997, 71: 925-33.
PubMed Central
CAS
PubMed
Google Scholar
Gauduin MC, Parren PW, Weir R, Barbas CF, Burton DR, Koup RA: Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1. Nat Med. 1997, 3: 1389-93. 10.1038/nm1297-1389.
Article
CAS
PubMed
Google Scholar
Aasa-Chapman MM, Holuigue S, Aubin K, Wong M, Jones NA, Cornforth D, Pellegrino P, Newton P, Williams I, Borrow P, McKnight A: Detection of antibody-dependent complement-mediated inactivation of both autologous and heterologous virus in primary human immunodeficiency virus type 1 infection. J Virol. 2005, 79: 2823-30. 10.1128/JVI.79.5.2823-2830.2005.
Article
PubMed Central
CAS
PubMed
Google Scholar
Huber M, Fischer M, Misselwitz B, Manrique A, Kuster H, Niederöst B, Weber R, von Wyl V, Günthard HF, Trkola A: Complement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infection. PLoS Med. 2006, 3: e441-10.1371/journal.pmed.0030441.
Article
PubMed Central
PubMed
Google Scholar
Trkola A, Kuster H, Rusert P, Joos B, Fischer M, Leemann C, Manrique A, Huber M, Rehr M, Oxenius A, Weber R, Stiegler G, Vcelar B, Katinger H, Aceto L, Günthard HF: Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies. Nat Med. 2005, 11: 615-22. 10.1038/nm1244.
Article
CAS
PubMed
Google Scholar
Evans DT, Bricker JE, Desrosiers RC: A novel approach for producing lentiviruses that are limited to a single cycle of infection. J Virol. 2004, 78: 11715-25. 10.1128/JVI.78.21.11715-11725.2004.
Article
PubMed Central
CAS
PubMed
Google Scholar
Kuate S, Stahl-Hennig C, ten Haaf P, Heeney J, Uberla K: Single-cycle immunodeficiency viruses provide strategies for uncoupling in vivo expression levels from viral replicative capacity and for mimicking live-attenuated SIV vaccines. Virology. 2003, 313: 653-62. 10.1016/S0042-6822(03)00388-X.
Article
CAS
PubMed
Google Scholar
Stahl-Hennig C, Steinman RM, Ten Haaft P, Uberla K, Stolte N, Saeland S, Tenner-Racz K, Racz P: The simian immunodeficiency virus deltaNef vaccine, after application to the tonsils of Rhesus macaques, replicates primarily within CD4(+) T cells and elicits a local perforin-positive CD8(+) T-cell response. J Virol. 2002, 76: 688-96. 10.1128/JVI.76.2.688-696.2002.
Article
PubMed Central
CAS
PubMed
Google Scholar
Tenner-Racz K, Stahl Hennig C, Uberla K, Stoiber H, Ignatius R, Heeney J, Steinman RM, Racz P: Early protection against pathogenic virus infection at a mucosal challenge site after vaccination with attenuated simian immunodeficiency virus. Proc Natl Acad Sci USA. 2004, 101: 3017-22. 10.1073/pnas.0308677101.
Article
PubMed Central
CAS
PubMed
Google Scholar
Gundlach BR, Lewis MG, Sopper S, Schnell T, Sodroski J, Stahl-Hennig C, Uberla K: Evidence for recombination of live, attenuated immunodeficiency virus vaccine with challenge virus to a more virulent strain. J Virol. 2000, 74: 3537-42. 10.1128/JVI.74.8.3537-3542.2000.
Article
PubMed Central
CAS
PubMed
Google Scholar
Hofmann-Lehmann R, Vlasak J, Williams A, Chenine A, McClure H, Anderson D, O'Neil S, Ruprecht R: Live-attenuated, nef-deleted SIV is pathogenic in most adult macaques after prolonged observation. AIDS. 2003, 17: 157-166. 10.1097/00002030-200301240-00004.
Article
CAS
PubMed
Google Scholar
Burns JC, Friedmann T, Driever W, Burrascano M, Yee JK: Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA. 1993, 90: 8033-7. 10.1073/pnas.90.17.8033.
Article
PubMed Central
CAS
PubMed
Google Scholar
Stahl-Hennig C, Kuate S, Franz M, Suh YS, Stoiber H, Sauermann U, Tenner-Racz K, Norley S, Park KS, Sung YC, Steinman R, Racz P, Uberla K: Atraumatic oral spray immunization with replication-deficient viral vector vaccines. J Virol. 2007, 81: 13180-90. 10.1128/JVI.01400-07.
Article
PubMed Central
CAS
PubMed
Google Scholar
Suh YS, Park KS, Sauermann U, Franz M, Norley S, Wilfingseder D, Stoiber H, Fagrouch Z, Heeney J, Hunsmann G, Stahl-Hennig C, Sung YC: Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model. Vaccine. 2006, 24: 1811-20.
Article
CAS
PubMed
Google Scholar
Evans DT, Bricker JE, Sanford HB, Lang S, Carville A, Richardson BA, Piatak M, Lifson JD, Mansfield KG, Desrosiers RC: Immunization of macaques with single-cycle simian immunodeficiency virus (SIV) stimulates diverse virus-specific immune responses and reduces viral loads after challenge with SIVmac239. J Virol. 2005, 79: 7707-20. 10.1128/JVI.79.12.7707-7720.2005.
Article
PubMed Central
CAS
PubMed
Google Scholar
Lifson JD, Nowak MA, Goldstein S, Rossio JL, Kinter A, Vasquez G, Wiltrout TA, Brown C, Schneider D, Wahl L, Lloyd AL, Williams J, Elkins WR, Fauci AS, Hirsch VM: The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection. J Virol. 1997, 71: 9508-14.
PubMed Central
CAS
PubMed
Google Scholar
Zhang ZQ, Schleif WA, Casimiro DR, Handt L, Chen M, Davies ME, Liang X, Fu TM, Tang A, Wilson KA, McElhaugh M, Carella A, Tan C, Connolly B, Hill S, Klein H, Emini EA, Shiver JW: The impact of early immune destruction on the kinetics of postacute viral replication in rhesus monkey infected with the simian-human immunodeficiency virus 89.6P. Virology. 2004, 320: 75-84. 10.1016/j.virol.2003.11.017.
Article
CAS
PubMed
Google Scholar
Quinnan GV, Yu XF, Lewis MG, Zhang PF, Sutter G, Silvera P, Dong M, Choudhary A, Sarkis PT, Bouma P, Zhang Z, Montefiori DC, Vancott TC, Broder CC: Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells. J Virol. 2005, 79: 3358-69. 10.1128/JVI.79.6.3358-3369.2005.
Article
PubMed Central
CAS
PubMed
Google Scholar
Trkola A, Kuster H, Rusert P, von Wyl V, Leemann C, Weber R, Stiegler G, Katinger H, Joos B, Günthard HF: In vivo efficacy of human immunodeficiency virus neutralizing antibodies: estimates for protective titers. J Virol. 2008, 82: 1591-9. 10.1128/JVI.01792-07.
Article
PubMed Central
CAS
PubMed
Google Scholar
Huber M, Trkola A: Humoral immunity to HIV-1: neutralization and beyond. J Intern Med. 2007, 262: 5-25. 10.1111/j.1365-2796.2007.01819.x.
Article
CAS
PubMed
Google Scholar
Florese RH, Van Rompay KK, Aldrich K, Forthal DN, Landucci G, Mahalanabis M, Haigwood N, Venzon D, Kalyanaraman VS, Marthas ML, Robert-Guroff M: Evaluation of passively transferred, nonneutralizing antibody-dependent cellular cytotoxicity-mediating IgG in protection of neonatal rhesus macaques against oral SIVmac251 challenge. J Immunol. 2006, 177: 4028-36.
Article
CAS
PubMed
Google Scholar
Hessell AJ, Hangartner L, Hunter M, Havenith CE, Beurskens FJ, Bakker JM, Lanigan CM, Landucci G, Forthal DN, Parren PW, Marx PA, Burton DR: Fc receptor but not complement binding is important in antibody protection against HIV. Nature. 2007, 449: 101-4. 10.1038/nature06106.
Article
CAS
PubMed
Google Scholar
Doepper S, Stoiber H, Kacani L, Sprinzl G, Steindl F, Prodinger WM, Dierich MP: B cell-mediated infection of stimulated and unstimulated autologous T lymphocytes with HIV-1: role of complement. Immunobiology. 2000, 202: 293-305.
Article
CAS
PubMed
Google Scholar
Döpper S, Wilflingseder D, Prodinger WM, Stiegler G, Speth C, Dierich MP, Stoiber H: Mechanism(s) promoting HIV-1 infection of primary unstimulated T lymphocytes in autologous B cell/T cell co-cultures. Eur J Immunol. 2003, 33: 2098-107. 10.1002/eji.200323932.
Article
PubMed
Google Scholar
Pruenster M, Wilflingseder D, Bánki Z, Ammann CG, Muellauer B, Meyer M, Speth C, Dierich MP, Stoiber H: C-type lectin-independent interaction of complement opsonized HIV with monocyte-derived dendritic cells. Eur J Immunol. 2005, 35: 2691-8. 10.1002/eji.200425940.
Article
CAS
PubMed
Google Scholar
Stoiber H, Pruenster M, Ammann CG, Dierich MP: Complement-opsonized HIV: the free rider on its way to infection. Mol Immunol. 2005, 42: 153-60. 10.1016/j.molimm.2004.06.024.
Article
CAS
PubMed
Google Scholar
Sullivan BL, Takefman DM, Spear GT: Complement can neutralize HIV-1 plasma virus by a C5-independent mechanism. Virology. 1998, 248: 173-81. 10.1006/viro.1998.9289.
Article
CAS
PubMed
Google Scholar
Scherl M, Posch U, Obermoser G, Ammann C, Sepp N, Ulmer H, Dierich MP, Stoiber H, Falkensammer B: Targeting human immunodeficiency virus type 1 with antibodies derived from patients with connective tissue disease. Lupus. 2006, 15: 865-72. 10.1177/0961203306071405.
Article
CAS
PubMed
Google Scholar
Nemerow GR, Cooper NR: Isolation of Epstein Barr-virus and studies of its neutralization by human IgG and complement. J Immunol. 1981, 127: 272-278.
CAS
PubMed
Google Scholar
Huber M, von Wyl V, Ammann CG, Kuster H, Stiegler G, Katinger H, Weber R, Fischer M, Stoiber H, Günthard HF, Trkola A: Potent HIV-Neutralizing and Complement Lysis Activity of Antibodies Are Not Obligatorily Linked. J Virol. 2008, 82: 3834-42. 10.1128/JVI.02569-07.
Article
PubMed Central
CAS
PubMed
Google Scholar
Schmitz JE, Johnson RP, McClure HM, Manson KH, Wyand MS, Kuroda MJ, Lifton MA, Khunkhun RS, McEvers KJ, Gillis J, Piatak M, Lifson JD, Grosschupff G, Racz P, Tenner-Racz K, Rieber EP, Kuus-Reichel K, Gelman RS, Letvin NL, Montefiori DC, Ruprecht RM, Desrosiers RC, Reimann KA: Effect of CD8+ lymphocyte depletion on virus containment after simian immunodeficiency virus SIVmac251 challenge of live attenuated SIVmac239delta3-vaccinated rhesus macaques. J Virol. 2005, 79: 8131-41. 10.1128/JVI.79.13.8131-8141.2005.
Article
PubMed Central
CAS
PubMed
Google Scholar
Stahl-Hennig C, Dittmer U, Nisslein T, Petry H, Jurkiewicz E, Fuchs D, Wachter H, Mätz-Rensing K, Kuhn EM, Kaup FJ, Rud EW, Hunsmann G: Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus. J Gen Virol. 1996, 77: 2969-81. 10.1099/0022-1317-77-12-2969.
Article
CAS
PubMed
Google Scholar
Stahl-Hennig C, Eisenblatter M, Franz M, Stoiber H, Tenner-Racz K, Suh YS, Jasny E, Falkensammer B, Ugucchioni M, Georgsson G, Baroni C, Dierich MP, Lifson JD, Steinman RM, Uberla K, Racz P, Ignatius R: A single vaccination with attenuated SIVmac 239 via the tonsillar route confers partial protection against challenge with SIVmac 251 at a distant mucosal site, the rectum. Front Biosci. 2007, 12: 2107-23. 10.2741/2215.
Article
CAS
PubMed
Google Scholar
Kuate S, Stahl-Hennig C, Stoiber H, Nchinda G, Floto A, Franz M, Sauermann U, Bredl S, Deml L, Ignatius R, Norley S, Racz P, Tenner-Racz K, Steinman RM, Wagner R, Uberla K: Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus. Virology. 2006, 351: 133-44. 10.1016/j.virol.2006.03.009.
Article
CAS
PubMed
Google Scholar
Stahl-Hennig C, Steinman RM, Tenner-Racz K, Pope M, Stolte N, Mätz-Rensing K, Grobschupff G, Raschdorff B, Hunsmann G, Racz P: Rapid infection of oral mucosal-associated lymphoid tissue with simian immunodeficiency virus. Science. 1999, 285: 1261-5. 10.1126/science.285.5431.1261.
Article
CAS
PubMed
Google Scholar
Schnell T, Foley P, Wirth M, Münch J, Überla K: Development of a self-inactivating, minimal lentivirus vector based on simian immunodeficiency virus. Hum Gene Ther. 2000, 11: 439-447. 10.1089/10430340050015905.
Article
CAS
PubMed
Google Scholar
He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B: A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA. 1998, 95: 2509-14. 10.1073/pnas.95.5.2509.
Article
PubMed Central
CAS
PubMed
Google Scholar
Letvin NL: Progress in the development of an HIV-1 vaccine. Science. 1998, 280: 1875-80. 10.1126/science.280.5371.1875.
Article
CAS
PubMed
Google Scholar
Spring M, Stahl-Hennig C, Nisslein T, Locher C, Fuchs D, Bodemer W, Hunsmann G, Dittmer U: Suppression of viral replication in a long-term non-progressing rhesus macaque experimentally infected with pathogenic simian immunodeficiency virus (SIV). Clin Immunol Immunopathol. 1998, 87: 101-105. 10.1006/clin.1997.4511.
Article
CAS
PubMed
Google Scholar
Hofmann-Lehmann R, Swenerton RK, Liska V, Leutenegger CM, Lutz H, McClure HM, Ruprecht RM: Sensitive and robust one-tube real-time reverse transcriptase-polymerase chain reaction to quantify SIV RNA load: comparison of one- versus two-enzyme systems. AIDS Res Hum Retroviruses. 2000, 16: 1247-57. 10.1089/08892220050117014.
Article
CAS
PubMed
Google Scholar
Akari H, Mori K, Terao K, Otani I, Fukasawa M, Mukai R, Yoshikawa Y: In vitro immortalization of Old World monkey T lymphocytes with Herpesvirus saimiri: its susceptibility to infection with simian immunodeficiency viruses. Virology. 1996, 218: 382-8. 10.1006/viro.1996.0207.
Article
CAS
PubMed
Google Scholar
Frank I, Stoiber H, Godar S, Stockinger H, Steindl F, Katinger HW, Dierich MP: Acquisition of host cell-surface-derived molecules by HIV-1. AIDS. 1996, 10: 1611-20.
Article
CAS
PubMed
Google Scholar